Bioxytran Launches Joint Venture with the Heme Foundation for Development of Universal Oxygen Carrier

Stock Information for Biolargo Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Biolargo Inc

Presenting on the Emerging Growth Conference 74 Day 2 on August 22 Register Now
Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
Bioxytran's Advisor Releases Book on Hyperbaric Oxygenation Related to Stroke & Alzheimer's Patients
Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
Presenting on the Emerging Growth Conference 70 Day 1 on May 8 Register Now
Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
Bioxytran Announces Preprint of Shingles Case Study Showing Clearance Using a Topical Galectin-3 Antagonist
Bioxytran's Oral Antiviral Drug to Enter Dose Optimization Clinical Trial for COVID-19

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.